Overview
- Several plaintiff law firms have filed or announced securities class actions against PROCEPT BioRobotics and are soliciting investors to join and seek lead-plaintiff roles by the September 22, 2026 deadline.
- The complaints center on an alleged undisclosed discount program that encouraged bulk handpiece orders and pulled future demand into earlier quarters, a practice plaintiffs say inflated reported U.S. handpiece unit sales and revenue.
- Company disclosures in August 2025, November 2025 and February 25, 2026 revealed deteriorating handpiece shipments, reduced guidance and that cumulative excess field inventory exceeded 10,000 units, triggering sharp stock declines.
- At least one complaint is pending in the U.S. District Court for the Northern District of California and the suits assert violations of Section 10(b), Section 20(a) and Rule 10b-5 while no class has yet been certified.
- If appointed, a lead plaintiff would steer litigation that could affect investor recoveries and Procept’s finances and the competing filings by multiple firms may shape settlement dynamics and the pace of discovery.